SLC14A1 and colorectal carcinoma: More importantly, the upregulation of SLC14A1 is closely associated with metachronous liver metastasis and poor prognosis in CRC patients, indicating its potential as a predictive marker for postoperative metachronous liver metastasis in these patients.